Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

BACKGROUND: Epidermolysis bullosa (EB) patient anecdotes and case reports indicate that cannabinoid-based medicines (CBMs) may alleviate pain and pruritus and improve wound healing. CBM use has not been characterized in the EB patient population. OBJECTIVES: To evaluate CBM use among EB patients, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schräder, Nicholas H. B., Gorell, Emily S., Stewart, Roy E., Duipmans, José C., Harris, Nicole, Perez, Victoria A., Tang, Jean Y., Wolff, André P., Bolling, Marieke C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419930/
https://www.ncbi.nlm.nih.gov/pubmed/34488820
http://dx.doi.org/10.1186/s13023-021-02010-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419930/
https://www.ncbi.nlm.nih.gov/pubmed/34488820
http://dx.doi.org/10.1186/s13023-021-02010-0

Ejemplares similares